Responses
Section 1: Introductory statements and governance
1ISG-007 HTA analysis for the inclusion of Andexanet Alfa (AA) within the Hospital Therapeutic Handbook (HTH) – the experience of an Italian centre specialising in cardiovascular diseases
Compose a Response to This Article
Other responses
No responses have been published for this article.